Search
for
Sort by
Research 121–150 of 276
- Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?
- Targeting integrin pathways: mechanisms and advances in therapy
- Finasteride and sexual side effects
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Teratogenic effect of isotretinoin in both fertile females and males (Review)
- Exploring the reality of exosomes in dermatology
- Teneligliptin-induced hair loss: A case report
- Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives
- Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- Present and Future Use of Exosomes in Dermatology
- Cutaneous Side Effects of Sports Supplements
- Role of Drug Repurposing in Sustainable Drug Discovery
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- A Gender Hypothesis of sex disparities in adverse drug events
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Fibroblast Growth Factor-7 and Hair Biology: Bridging Basic Science and Therapeutic Applications
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes